Introduction
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise: $513.7m sales in 2008 fall far short of analyst predictions.
Reasons to Purchase
*Understand why predictions for this market have been repeatedly over-stated
*Qualify market expectations against the practicalities of targeting this unyielding market
*Assess the qualities of marketed and pipeline products and their commercial handling to determine their realistic prospects
Other selected research from the 'Markets' category:
Medical Nanotechnology Markets
This report covers the specific segments of the medical nanotechnology markets, with particular emphasis on those segments where this emerging technology is or shows the potential to be most impactful. Learn More
Partneringreview 2006 - Industry sector (volume 6)
Other selected research from the 'Metabolic disorders' category:
Deals and alliances in gastrointestinal diseases
Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
Weight loss and diet management is a challenge for millions of people around the world. Globally, more than 1 billion people are above an ideal weight. The affects weight has... Learn More